antiCD49d Ab treatment ameliorates age-associated inflammatory response and mitigates CD8 T cell cytotoxicity after traumatic brain injury
Zhangying Chen, Kacie P. Ford, Mecca B.A.R. Islam, Hanxiao Wan, Hyebin Han, Abhirami Ramakrishnan, R. J. Brown, Veronica Villanueva, Yidan Wang, Booker T. Davis, Craig Weiss, Weiguo Cui, David Gate, Steven J. Schwulst
This study shows that anti-CD49d antibody treatment reduces age-related inflammatory responses and CD8 T cell cytotoxicity after traumatic brain injury in mice.
Journal of Neuroinflammation · Oct 19, 2024Peer-reviewedImmunology